Delivery Order SPE2DB22D1017-SPE2DB25FG1EC

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,289.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Forteo 560 mcg/2.24 ml pen injections. It is a firm-fixed-price delivery order with a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Forteo 600 mcg/2.4 ml pen injections. The $3,544.12 firm-fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 600 mcg/2.4 ml Forteo Pen Injections. The $27,448.06 firm fixed-price contract has a completion date of November 29, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Forteo 600 mcg/2.4 ml pen injections. The fixed-price delivery order, valued at $2,749.98, does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,772.06 firm fixed-price delivery order is for the supply of 600 mcg/2.4 ml Forteo pen injections. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,677.47 firm-fixed-price contract is for the delivery of Forteo 560 mcg/2.24 ml pen injections. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that allows AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military...
This federal contract award, valued at $1,772.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Forteo 600 MCG/2.4 ML Pen Inj 2.4ML, a prescription medication. This is a delivery order contract with a firm fixed price structure. The contract has an ultimate completion date of August 28, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a firm fixed price delivery order with a ceiling value of $2,658.09. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, for the provision of Forteo 600 mcg/2.4 ml pen injectors. The delivery order is a component of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of the drug Forteo (teriparatide) 600 mcg/2.4 ml pen injection. The contract has a ceiling value of $5,316.18 and is a firm fixed-price delivery order with a completion date of May 14, 2024. Amerisourcebergen is a subsidiary of Cencora, Inc. and this award is not associated with a set-aside designation. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,024.35 firm-fixed-price delivery order contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG1EC
    Delivery Order

This federal contract award, valued at $4,451.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the medication Forteo 560 mcg/2.24 ml pen injection, with an ultimate completion date of April 29, 2025.

The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00. This IDC, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. It allows Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

The contract award is not designated as a set-aside, indicating open competition. As a major supplier of medical and pharmaceutical products to federal agencies, Amerisourcebergen Drug Corp plays a critical role in delivering diverse healthcare-related supplies, including medications across multiple therapeutic domains, to support the medical and pharmaceutical needs of various government agencies.

Generated 7/28/25, 11:00 AM